STALICLA signs Cooperative Research and Development Agreement (CRADA) with US National Institute on Drug Abuse (NIDA) to cover Phase 3 development of mavoglurant in cocaine use disorder 8-03-2023, 18:00

Tealium customers achieve 25% increase in return-on-ad spend via CAPI integration capabilities 23-04-2025, 21:15

Anaqua to Host Annual User Experience Conference with Keynotes from BASF, Copyright Clearance Center, and IBM 14-06-2023, 18:00